Moderna's vaccine that targets the omicron variant gets its first approval as British regulators authorize it

British drug regulators have become the first in the world to authorize an updated version of Moderna’s coronavirus vaccine that aims to protect against the omicron variant.

LONDON — British drug regulators have become the first in the world to authorize an updated version of Moderna’s coronavirus vaccine that aims to protect against the original virus and the omicron variant.

In a statement on Monday, the Medicines and Healthcare Regulatory Agency said it had given the green light to Moderna’s combination “bivalent” vaccine, which will be used as an adult booster shot.

Each dose of the booster shot will target both the original Covid-19 virus and the omicron BA.1 variant that was first picked up in November. British regulators said the side effects were similar to those seen for Moderna’s original booster shot and were typically “mild and self-resolving.”

Children under 5 begin receiving Covid vaccineJune 22, 202204:12“What this (combination) vaccine gives us is a sharpened tool in our armory to help protect us against this disease as the virus continues to evolve,” said Dr. June Raine, the head of Britain’s health care and medicines regulator.

Such an approach is used with flu shots, which are adjusted each year depending on the variants that are circulating and can protect against four influenza strains.

https://www.nbcnews.com/news/world/modernas-vaccine-targets-omicron-variant-gets-first-approval-authorize-rcna43093


Post ID: 936e7597-b471-4a6c-8b71-896584102346
Rating: 5
Updated: 1 year ago
Your ad can be here
Create Post

Similar classified ads


News's other ads